[HTML][HTML] 2020 Korean Society for the Study of Obesity guidelines for the management of obesity in Korea

BY Kim, SM Kang, JH Kang, SY Kang… - Journal of obesity & …, 2021 - ncbi.nlm.nih.gov
Obesity is a prevalent and complex disease. The prevalence of obesity in Korea increased
from 29.7% in 2010 to 35.7% in 2018, with the prevalence of abdominal obesity being …

A review on coronary artery disease, its risk factors, and therapeutics

AK Malakar, D Choudhury, B Halder… - Journal of cellular …, 2019 - Wiley Online Library
Coronary artery disease (CAD) is one of the major cardiovascular diseases affecting the
global human population. This disease has been proved to be the major cause of death in …

[HTML][HTML] The global burden of metabolic disease: Data from 2000 to 2019

NWS Chew, CH Ng, DJH Tan, G Kong, C Lin, YH Chin… - Cell Metabolism, 2023 - cell.com
Global estimates of prevalence, deaths, and disability-adjusted life years (DALYs) from the
Global Burden of Diseases, Injuries, and Risk Factors Study 2019 were examined for …

Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes

R Wagner, M Heni, AG Tabak, J Machann, F Schick… - Nature medicine, 2021 - nature.com
The state of intermediate hyperglycemia is indicative of elevated risk of developing type 2
diabetes. However, the current definition of prediabetes neither reflects subphenotypes of …

Metabolic syndrome: past, present and future

I Lemieux, JP Després - Nutrients, 2020 - mdpi.com
Most clinicians and health professionals have heard or read about metabolic syndrome. For
instance, as of October 2020, entering “metabolic syndrome” in a PubMed search generated …

Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017

M Kinoshita, K Yokote, H Arai, M Iida… - … of atherosclerosis and …, 2018 - jstage.jst.go.jp
Every 5 years, the JAS publishes guidelines for the treatment of dyslipidemia and
atherosclerosis. To date, this society has released four such guidelines. Since 2007, the JAS …

NAD+ intermediates: the biology and therapeutic potential of NMN and NR

J Yoshino, JA Baur, S Imai - Cell metabolism, 2018 - cell.com
Research on the biology of NAD+ has been gaining momentum, providing many critical
insights into the pathogenesis of age-associated functional decline and diseases. In …

Pathophysiology of the metabolic syndrome

E McCracken, M Monaghan, S Sreenivasan - Clinics in dermatology, 2018 - Elsevier
The metabolic syndrome—otherwise called syndrome X, insulin resistance syndrome,
Reaven syndrome, and “the deadly quartet”—is the name given to the aggregate of clinical …

Atualização da diretriz brasileira de dislipidemias e prevenção da aterosclerose–2017

AA Faludi, MCO Izar, JFK Saraiva… - Arquivos brasileiros de …, 2017 - SciELO Brasil
Material de distribuição exclusiva à classe médica. Os Arquivos Brasileiros de Cardiologia
não se responsabilizam pelo acesso indevido a seu conteúdo e que contrarie a …

Erectile dysfunction and diabetes: A melting pot of circumstances and treatments

G Defeudis, R Mazzilli, M Tenuta… - Diabetes/metabolism …, 2022 - Wiley Online Library
Diabetes mellitus (DM), a chronic metabolic disease characterised by elevated levels of
blood glucose, is among the most common chronic diseases. The incidence and prevalence …